Tenoxicam Ps.Inj.Sol 20mg/Vial (EU CTD Available)

Product Description

Tenoxicam 20 mg/Vial Powder for Solution for Injection Reference Product: Tilcitin® / Meda 
Description:  Tenoxicam is used in patients considered unable to take oral tenoxicam for the relief of pain and inflammation in osteoarthritis and rheumatoid arthritis and for the short-term management of acutemusculoskeletal disorders including strains, sprain sand other soft-tissue injuries.
Dossier Status: On-going / EU CTD Available
Stability Studies: Zone II / Zone IVb
Shelf life (Originator): Three (3) years 
Batch Sizes: 27,000 vials
Pack Sizes: BT x 1 vial

ANFARM HELLAS S.A.

  • Country/Region:
    Greece
  • On CPHI since:
    2015
Primary activities
Contract Manufacturer
Pharmaceutical Company (generic finished products)
Regulatory Affairs
Supply Chain
Specifications
  • Selling Points
    International Approvals/Standards
  • Supplied from
    Greece

ANFARM HELLAS S.A.

  • Country/Region:
    Greece
  • On CPHI since:
    2015
Primary activities
Contract Manufacturer
Pharmaceutical Company (generic finished products)
Regulatory Affairs
Supply Chain

More Products from ANFARM HELLAS S.A. (41)

  • Omeprazole Pd.Sol.Inf 40mg/vial (EU CTD Available)

    Product Omeprazole Pd.Sol.Inf 40mg/vial (EU CTD Available)

    Reference Product: Losec® / Astra Zeneca Powder for Solution for InfusionDescription: Omeprazole belongs to the ATC category of Proton-pump inhibitors which is a group of drugs whose main action is a pronounced and long-lasting reduction of stomach acid production.Due to their effective acid-suppressing ef...
  • Omeprazole Ps.Inj.Sol 40mg/vial (EU CTD Available)

    Product Omeprazole Ps.Inj.Sol 40mg/vial (EU CTD Available)

    Omeprazole 40mg/vial Powder for Solution for Injection  Reference Product: Losec® / Astra Zeneca
    Description: Omeprazole belongs to the ATC category of Proton-pump inhibitors which is a group of drugs whose main action is a pronounced and long-lasting reduction of stomach acid production.Due t...
  • Palonosetron Inj.Sol. 250mcg/5ml (Vial) (EU CTD Available)

    Product Palonosetron Inj.Sol. 250mcg/5ml (Vial) (EU CTD Available)

    Palonosetron 250mcg/5ml (Vial) Solution for Injection
    Reference Product: Aloxi® / Helsinn
    Description: Palonosetron is an antiemetic and antinauseant agent belonging to serotonin (5HT3) antagonists category.
    Palonosetron is indicated in adults and paediatric patients 1 month of age and older for t...
  • Pantoprazole Pd.Inj.Sol 40mg/Vial (EU CTD Available)

    Product Pantoprazole Pd.Inj.Sol 40mg/Vial (EU CTD Available)

    Pantoprazole 40 mg/Vial Powder for Solution for Injection
    Reference Product: Controloc® / Takeda
    Description: Pantoprazoleis a proton pump inhibitor indicated for the treatment of the Gastroesophageal Reflux Disease (GERD) with erosive esophagitis (EE) and in Pathological hypersecretion ...
  • Somatostatin Ps.Sol.Inf. 3mg/Vial (EU CTD Available)

    Product Somatostatin Ps.Sol.Inf. 3mg/Vial (EU CTD Available)

    Somatostatin 3mg/Vial Powder for Solution for Infusion
    Reference Product: Stilamin® / MSD Description: Somatostatin is indicated in cases of Growth Hormone Hypersecretion (ACROMEGALITY)
    Dossier Status: EU CTD Available
    Stability Studies: Zone II / Zone IVb
    Shelf life (Origi...
  • Sugammadex Inj.Sol. 100mg/ml (2 & 5 ml Vial) (EU CTD Available)

    Product Sugammadex Inj.Sol. 100mg/ml (2 & 5 ml Vial) (EU CTD Available)

    Sugammadex 100mg/ml (2 & 5 ml Vial) Solution for Injection
    Reference Product: Bridion® / MSD
    Description: Sugammadex is a modified gamma cyclodextrin which is a Selective Relaxant Binding Agent. 
    It forms a complex with the neuromuscular blocking agents rocuronium or vecuronium in plasma ...
  • Tigecycline Pd.Sol.Inf 50mg/Vial (EU CTD Available)

    Product Tigecycline Pd.Sol.Inf 50mg/Vial (EU CTD Available)

    Tigecycline 50 mg/Vial Powder for Solution for Infusion Reference Product: Tygacil® / Pfizer
    Description: Tigecycline, a glycylcycline antibiotic, inhibits protein translation in bacteria by binding to the 30S ribosomal subunitand blocking entry of amino-acyl tRNA molecules into the A site of the...
  • Vancomycin Pd.Sol.Inf 500mg/Vial (EU CTD Available) & 1g/vial (EU CT Available: Q3 2021)

    Product Vancomycin Pd.Sol.Inf 500mg/Vial (EU CTD Available) & 1g/vial (EU CT Available: Q3 2021)

    Vancomycin Vial Powder for Solution for Infusion
    Reference Product: Voncon® / Lilly
    Description: Vancomycin Hydrochloride is a glycopeptide antibacterial indicated in adult and pediatric patients (neonates and older) for the treatment of Septicemia, Infective Endocarditis, Ski...
  • Vildagliptin & Metformin Tabs (50+850 mg), (50+1000 mg) (EU CTD Available: Q3 2021)

    Product Vildagliptin & Metformin Tabs (50+850 mg), (50+1000 mg) (EU CTD Available: Q3 2021)

    Vildagliptin & Metformin(50+850 mg), (50+1000 mg) Film Coated Tablets Reference Product: Eucreas® / Novartis 
    Description: Vildagliptin & Metformin is a combination of 2 anti-diabetic agents indicated in the treatment of type 2 diabetes mellitus. More specifically, it is indicated...
  • Voriconazole Pd.Sol.Inf 200mg/Vial (EU CTD Available)

    Product Voriconazole Pd.Sol.Inf 200mg/Vial (EU CTD Available)

    Voriconazole 200 mg/Vial Powder for Solution for Infusion
    Reference Product: Vfend® / Pfizer
    Description: In the treatment of the following fungal infections: Invasive aspergillosis, Candidemia, Esophageal candidiasis, Serious fungal infections caused ...
  • Aripiprazole Oral Solution 1mg/ml

    Product Aripiprazole Oral Solution 1mg/ml

    Abilify Maintena is an antipsychotic medicine that contains the active substance aripiprazole. It is used for the maintenance treatment of schizophrenia in adults whose disease has already been stabilised with aripiprazole taken by mouth.

    The exact way it works is not known but it attac...
  • Ceftazidime/ Avibactam Pd.C.S.Inf (2+0.5)g/vial

    Product Ceftazidime/ Avibactam Pd.C.S.Inf (2+0.5)g/vial

    Ceftazidime Avibactam is indicated in adults and pediatric patients aged 3 months and older for the treatment of the following infections:

    ·        Complicated intra-abdominal infection (cIAI)

    ·        Co...

ANFARM HELLAS S.A. resources (22)